medigraphic.com
ISSN 1561-2937 (Print)

2015, Number 2

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2015; 21 (2)

Detection of infectious agents and others atherosclerotic factors in patients undergoing cardiac surgery

Colao JY, Correa SC, Kouri CV, Abi-Rezk MN, González NY, Ramírez HM

Language: Spanish
References: 15
Page: 94-99
PDF size: 253.67 Kb.


ABSTRACT

We studied 34 patients, from july 1 to august 31, 2014 at Ameijeiras hospital. A cardiac surgery were performed in all of them, 18 with coronary disease and 16 with valvular disease (10 aortic and 6 mitral) this work was approved by the Ethics Committee responsible for this investigation. We determined they serological status in relation with cytomegalovirus (CMV) and herpes simple virus (HSV) before cardiac surgery and we used samples of tissues during surgery (Left Internal mammary artery, 18.Right Internal mammary artery, 1. Ascending Aortic wall 9, Valvular tissues, 16) to find DNA of cytomegalovirus, herpes simple virus and Clamidophila pneumonia with PCR. The most frecuent risk factor was smoking habit (64,7%), represent 61,1% in coronary disease group and 68,7% in valvulvar. Hypertension was the second one risk factor (58,8%), particulary elevated in coronary disease group(66,6%). The patients in coronary group positive IgG against CMV represent the 77, 7% and with IgG against HSV 66,6%. In the valvular group positive IgG against CMV represent the 68, 7% and with IgG against HSV 56,25%. No one sample of tissue showed genomic presence of C. pneumoniae, CMV or HSV with PCR.


REFERENCES

  1. Bess Constantén S. Anuario Estadístico de Salud. In: Cuba DNdRM y EdSd, editor. La Habana: Ministerio de Salud Pública; 2013.

  2. Ji YN, An L, Zhan P, Chen XH. Cytomegalovirus infection and coronary heart disease risk: a meta-analysis. Mol Biol Rep. 2012;39:6537-46.

  3. Hechter RC, Budoff M, Hodis HN, Rinaldo CR, Jenkins FJ, Jacobson LP, et al. Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: Multicenter AIDS Cohort Study. Atherosclerosis. 2012;223:433-6.

  4. Borel N, Pospischil A, Dowling RD, Dumrese C, Gaydos CA, Bunk S, et al. Antigens of persistent Chlamydia pneumoniae within coronary atheroma from patients undergoing heart transplantation. J Clin Pathol. 2012;65:171-7

  5. Folsom AR, Nieto FJ, Sorlie P, Chambless LE, Graham DY. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. Circulation. 1998;98:845-50.

  6. Corrado E, Novo S. Role of inflammation and infection in vascular disease. Acta Chir Belg. 2005;105:567-79.

  7. Mocarski ES, Shenk T, Pass RF. Cytomegaloviruses. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 2703-72.

  8. Roizman B, Knipe DM, Whitley RJ. Herpes Simplex Viruses. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 2503- 601.

  9. Al-Ghamdi A, Jiman-Fatani AA, El-Banna H. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease. Pak J Pharm Sci. 2011;24:95-101.

  10. Kurano M, Tsukamoto K. Etiology of atherosclerosis-- special reference to bacterial infection and viral infection. Nihon Rinsho. 2011;69:25-9.

  11. Belland RJ, Ouellette SP, Gieffers J, Byrne GI. Chlamydia pneumoniae and atherosclerosis. Cell Microbiol. 2004;6:117- 27.

  12. Resik S, Enamorado A, Tallo Y, Suarez C, Kouri V, Acosta B, et al. Prevalence of antibodies against herpes simplex virus, Epstein-Barr virus and cytomegalovirus in a group of patients after hemodialysis. Rev Cubana Med Trop. 1999;51:172-6.

  13. Correa CB, Kourí V, Verdasquera D, Martınez PA, Álvarez A, Aleman Y, et al. HCMV seroprevalence and associated risk factors in pregnant women, Havana City, 2007 to 2008. Prenatal Diagn. 2010;30:888-92.

  14. Alvarez R, Cour I, Kanaan A, Benedicto M, Martin-Estefania C, Arroyo R, et al. Detection of viral genomes of the Herpesviridae family in multiple sclerosis patients by means of the polymerase chain reaction (PCR). Enferm Infecc Microbiol Clin. 2000;18:223-8.

  15. Le Saux S, Weyand CM, Goronzy JJ. Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci. 2012;1247:69-82.




2020     |     www.medigraphic.com